tiprankstipranks
Belluscura PLC (GB:BELL)
LSE:BELL

Belluscura PLC (BELL) Share Price & Analysis

5 Followers

BELL Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range15.20p - 52.00p
Previous Close19.5p
Volume179.11K
Average Volume (3M)238.33K
Market Cap
£32.06M
Enterprise Value30.67M
Total Cash (Recent Filing)$2.04M
Total Debt (Recent Filing)$302.62K
Price to Earnings (P/E)-3.1
Beta0.59
Sep 02, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.07
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume238,328
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit450.40
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

10.90%0.00%0.00%89.10%
10.90% Insiders
0.00% Other Institutional Investors
89.10% Public Companies and
Individual Investors

BELL FAQ

What was Belluscura PLC’s price range in the past 12 months?
Belluscura PLC lowest share price was 15.20p and its highest was 52.00p in the past 12 months.
    What is Belluscura PLC’s market cap?
    Currently, no data Available
    When is Belluscura PLC’s upcoming earnings report date?
    Belluscura PLC’s upcoming earnings report date is Sep 02, 2024 which is in 157 days.
      How were Belluscura PLC’s earnings last quarter?
      Currently, no data Available
      Is Belluscura PLC overvalued?
      According to Wall Street analysts Belluscura PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Belluscura PLC pay dividends?
        Belluscura PLC does not currently pay dividends.
        What is Belluscura PLC’s EPS estimate?
        Belluscura PLC’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Belluscura PLC have?
        Belluscura PLC has 164,385,120 shares outstanding.
          What happened to Belluscura PLC’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Belluscura PLC?
          Currently, no hedge funds are holding shares in GB:BELL
          ---

          Belluscura PLC Stock Smart Score

          1
          Underperform
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          -48.00%
          12-Months-Change

          Fundamentals

          Return on Equity
          -41.90%
          Trailing 12-Months
          Asset Growth
          -3.52%
          Trailing 12-Months

          Company Description

          Belluscura PLC

          Belluscura PLC is a medical device company. Its first product, the X-PLO?RTM, is a lightweight FDA cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO?R weighs less than 1.5kg (3.25lbs) and it is the first modular portable oxygen concentrator and that it will generate more oxygen by weight than any other FDA cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          C4X Discovery Holdings
          ConvaTec
          EKF Diagnostics Holdings
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis